Jefferies Starts Acadia Healthcare (ACHC) at Buy
Get Alerts ACHC Hot Sheet
Price: $30.83 +1.95%
Rating Summary:
13 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies initiates coverage on Acadia Healthcare (NASDAQ: ACHC) with a Buy. PT $13.00.
The firm comments, "Led by the former Psychiatric Solutions executive management team, ACHC is well positioned to realize EPS growth of 25%+ through a combination of steady organic growth, improving margins and acquisitions of acute inpatient psychiatric facilities. In December 2011, Jefferies acted as a Joint Bookrunner in a follow-on equity offering for ACHC."
For an analyst ratings summary and ratings history on Acadia Healthcare click here. For more ratings news on Acadia Healthcare click here.
Shares of Acadia Healthcare closed at $9.77 yesterday.
The firm comments, "Led by the former Psychiatric Solutions executive management team, ACHC is well positioned to realize EPS growth of 25%+ through a combination of steady organic growth, improving margins and acquisitions of acute inpatient psychiatric facilities. In December 2011, Jefferies acted as a Joint Bookrunner in a follow-on equity offering for ACHC."
For an analyst ratings summary and ratings history on Acadia Healthcare click here. For more ratings news on Acadia Healthcare click here.
Shares of Acadia Healthcare closed at $9.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
- Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
- Leerink Starts Freenome Inc. (FRNM) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share